Abstract
It has been shown that the survival of patients with NSCLC is related to nodal involvement. Both BTS and SIGN guidelines recognise that simple nodal sampling is not adequate to accurately stage NSCLC and recommend at least systematic sampling of mediastinal nodes. In the West of Scotland all patients with node positive disease are considered for adjuvant chemotherapy. This requires accurate staging of lymph nodes.
Highlights
Background/Introduction It has been shown that the survival of patients with NSCLC is related to nodal involvement
Systematic lymph node sampling at operation results in more node positive staging in NSCLC
In the West of Scotland all patients with node positive disease are considered for adjuvant chemotherapy
Summary
Background/Introduction It has been shown that the survival of patients with NSCLC is related to nodal involvement. Systematic lymph node sampling at operation results in more node positive staging in NSCLC J Whiteley*, G Beattie, A McKay, A Kirk, M Asif From World Society of Cardiothoracic Surgeons 25th Anniversary Congress, Edinburgh Edinburgh, UK.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
